1. Home
  2. MLAB vs STK Comparison

MLAB vs STK Comparison

Compare MLAB & STK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLAB
  • STK
  • Stock Information
  • Founded
  • MLAB 1982
  • STK 2009
  • Country
  • MLAB United States
  • STK United States
  • Employees
  • MLAB N/A
  • STK N/A
  • Industry
  • MLAB Industrial Machinery/Components
  • STK Investment Managers
  • Sector
  • MLAB Industrials
  • STK Finance
  • Exchange
  • MLAB Nasdaq
  • STK Nasdaq
  • Market Cap
  • MLAB 680.0M
  • STK 545.8M
  • IPO Year
  • MLAB N/A
  • STK N/A
  • Fundamental
  • Price
  • MLAB $117.96
  • STK $27.90
  • Analyst Decision
  • MLAB Hold
  • STK
  • Analyst Count
  • MLAB 2
  • STK 0
  • Target Price
  • MLAB $140.00
  • STK N/A
  • AVG Volume (30 Days)
  • MLAB 48.0K
  • STK 38.2K
  • Earning Date
  • MLAB 02-04-2025
  • STK 01-01-0001
  • Dividend Yield
  • MLAB 0.54%
  • STK 6.60%
  • EPS Growth
  • MLAB N/A
  • STK N/A
  • EPS
  • MLAB N/A
  • STK N/A
  • Revenue
  • MLAB $237,747,000.00
  • STK N/A
  • Revenue This Year
  • MLAB $13.48
  • STK N/A
  • Revenue Next Year
  • MLAB $4.74
  • STK N/A
  • P/E Ratio
  • MLAB N/A
  • STK N/A
  • Revenue Growth
  • MLAB 11.68
  • STK N/A
  • 52 Week Low
  • MLAB $83.68
  • STK $24.95
  • 52 Week High
  • MLAB $155.12
  • STK $34.31
  • Technical
  • Relative Strength Index (RSI)
  • MLAB 37.05
  • STK 27.11
  • Support Level
  • MLAB $121.89
  • STK $29.15
  • Resistance Level
  • MLAB $130.12
  • STK $30.58
  • Average True Range (ATR)
  • MLAB 4.45
  • STK 0.54
  • MACD
  • MLAB -0.25
  • STK -0.02
  • Stochastic Oscillator
  • MLAB 18.72
  • STK 0.00

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About STK Columbia Seligman Premium Technology Growth Fund Inc

Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services. Columbia Management Investment Advisers, LLC serves as the investment manager to the fund.

Share on Social Networks: